Patient Portal

Timothy Rearden, MD

Associate Professor, Medicine

Division of Medical Oncology

Specialty Areas

Medical Oncology
Lung Cancer
Breast Cancer
Gastrointestinal Oncology

Board Certifications

Internal Medicine
Medical Oncology

Hospital Affiliations

Christian Hospital
Barnes-Jewish Hospital

Areas of Clinical Interest

Lung cancer, breast cancer, gastrointestinal cancer and lymphoma

  • Location(s)
  • Education
  • Publication & Research



Christian Hospital
Medical Office Building 1

11155 Dunn Road
St. Louis, MO 63136

Office Phone: 314-747-7222
Additional Phone: 800-600-3643



Fellowship, Hematology/Oncology: University of California - San Francisco, San Francisco, CA 1992
Fellowship, Hematology/Oncology: Letterman Army Medical Center, San Francisco, CA 1991
Residency, Internal Medicine: Letterman Army Medical Center, San Francisco, CA 1988
Medical Degree: University of Missouri-Columbia, Columbia, MO 1985

Publication & Research

Publication & Research

Small, EJ., Srinivas, S., Egan, B., McMillian, A., and Rearden, TP. Doxorubicin and Dose-Escalated Cyclophosphamide with Granulocyte Colony-Stimulating Factor for the Treatment of Hormone-Resistant Prostate Cancer. Journal of Clinical Oncology, Vol 14: 1617-1625, 1996.


Adkins, D., Brown, R., Trinkaus, K., Maziarz, R., Luedke, S., Freytes, C., Needles, B., Wienski, D., Fracasso, P., Pluard, T., Moriconi, W., Ryan, T., Hoelzer, K., Safdar, S., Rearden, T.p., et. Al. Outcomes of High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in Stage IIIB Inflammatory Breast Cancer. Journal of Clinical Oncology, Vol 17, No 7 (july), 1999: pg 2006-2014.


Schawrtzberg, L., Burkes, R., Mirtsching, B., Rearden, T., et. Al. Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial. BMC Cancer, Vol 10: 581. October 25, 2010.


Charu V, Saidman B, Ben-Jacob A, Justice GR, Maniam AS, Tomita D, Rossi G, Rearden T, Glaspy J. A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia. Oncologist. 2007 Oct;12(10):1253-63.